AS160 deficiency causes whole-body insulin resistance via composite effects in multiple tissues
Open Access
- 14 December 2012
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 449 (2), 479-489
- https://doi.org/10.1042/bj20120702
Abstract
AS160 (Akt substrate of 160 kDa) is a Rab GTPase-activating protein implicated in insulin control of GLUT4 (glucose transporter 4) trafficking. In humans, a truncation mutation (R363X) in one allele of AS160 decreased the expression of the protein and caused severe postprandial hyperinsulinaemia during puberty. To complement the limited studies possible in humans, we generated an AS160-knockout mouse. In wild-type mice, AS160 expression is relatively high in adipose tissue and soleus muscle, low in EDL (extensor digitorum longus) muscle and detectable in liver only after enrichment. Despite having lower blood glucose levels under both fasted and random-fed conditions, the AS160-knockout mice exhibited insulin resistance in both muscle and liver in a euglycaemic clamp study. Consistent with this paradoxical phenotype, basal glucose uptake was higher in AS160-knockout primary adipocytes and normal in isolated soleus muscle, but their insulin-stimulated glucose uptake and overall GLUT4 levels were markedly decreased. In contrast, insulin-stimulated glucose uptake and GLUT4 levels were normal in EDL muscle. The liver also contributes to the AS160-knockout phenotype via hepatic insulin resistance, elevated hepatic expression of phosphoenolpyruvate carboxykinase isoforms and pyruvate intolerance, which are indicative of increased gluconeogenesis. Overall, as well as its catalytic function, AS160 influences expression of other proteins, and its loss deregulates basal and insulin-regulated glucose homoeostasis, not only in tissues that normally express AS160, but also by influencing liver function.This publication has 40 references indexed in Scilit:
- Thr649Ala-AS160 knock-in mutation does not impair contraction/AICAR-induced glucose transport in mouse muscleAmerican Journal of Physiology-Endocrinology and Metabolism, 2012
- AS160 Phosphotyrosine-binding Domain Constructs Inhibit Insulin-stimulated GLUT4 Vesicle Fusion with the Plasma MembraneOnline Journal of Public Health Informatics, 2011
- Mice with AS160/TBC1D4-Thr649Ala Knockin Mutation Are Glucose Intolerant with Reduced Insulin Sensitivity and Altered GLUT4 TraffickingCell Metabolism, 2011
- A truncation mutation in TBC1D4 in a family with acanthosis nigricans and postprandial hyperinsulinemiaProceedings of the National Academy of Sciences of the United States of America, 2009
- Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 trafficAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Direct Quantification of Fusion Rate Reveals a Distal Role for AS160 in Insulin-stimulated Fusion of GLUT4 Storage VesiclesOnline Journal of Public Health Informatics, 2008
- Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activatorsBiochemical Journal, 2007
- Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF, PMA and AICARBiochemical Journal, 2007
- Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contractionThe EMBO Journal, 2005
- Insulin Stimulation of GLUT4 Exocytosis, but Not Its Inhibition of Endocytosis, Is Dependent on RabGAP AS160Molecular Biology of the Cell, 2004